期刊文献+

肝门部胆管癌解剖分型、肝脏功能与影像学评估 被引量:3

下载PDF
导出
摘要 近年来,肝门部胆管癌(hilar cholangiocarcinoma,HC)发病率有逐年增多趋势,鉴于HC位于解剖复杂的肝门区域,常合并门静脉、肝动脉及尾状叶胆管受累,常须联合肝切除才能达到根治目的,因此术前对HC解剖分型、肝脏功能及影像学评估非常重要。1肝门部胆管癌的解剖分型目前临床常用的分型方法有以下三种:一是1975年由Bismuth等[1]提出的Bismuth-Corlette分型,并于1988年进行了改良;二是美国癌症联合会(American joint committee on cancer,AJCC)提出的TNM分期,该分期定期更新,现已更新为第8版.
出处 《中国临床医生杂志》 2020年第6期634-636,F0002,共4页 Chinese Journal For Clinicians
基金 首都临床特色应用研究项目(Z181100001718214)
  • 相关文献

参考文献6

二级参考文献95

  • 1Jia-Yan Ni,Shan-Shan Liu,Lin-Feng Xu,Hong-Liang Sun,Yao-Ting Chen.Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma[J].World Journal of Gastroenterology,2013,19(24):3872-3882. 被引量:35
  • 2Sala M,Llovet JM,Vilana R,et al.Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology . 2004 被引量:2
  • 3William R. Jarnagin,Mithat Gonen,Yuman Fong,Ronald P. DeMatteo,Leah Ben-Porat,Sarah Little,Carlos Corvera,Sharon Weber,Leslie H. Blumgart.Improvement in Perioperative Outcome After Hepatic Resection: Analysis of 1,803 Consecutive Cases Over the Past Decade[J]. Annals of Surgery . 2002 (4) 被引量:5
  • 4Alejandro Forner,Josep M Llovet,Jordi Bruix.Hepatocellular carcinoma[J].The Lancet.2012(9822) 被引量:15
  • 5P. Faybik,H. Hetz.Plasma Disappearance Rate of Indocyanine Green in Liver Dysfunction[J].Transplantation Proceedings.2006(3) 被引量:3
  • 6European Association for the Study of the Liver,European Organisation for Research and Treatment of Cancer.EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma[J].Journal of Hepatology.2012(4) 被引量:41
  • 7Maurizio Pompili,Antonio Saviano,Nicoletta de Matthaeis,Alessandro Cucchetti,Francesco Ardito,Bruno Federico,Franco Brunello,Antonio D. Pinna,Antonio Giorgio,Stefano M. Giulini,Ilario De Sio,Guido Torzilli,Fabio Fornari,Lorenzo Capussotti,Alfredo Guglielmi,Fabio Piscaglia,Luca Aldrighetti,Eugenio Caturelli,Fulvio Calise,Gennaro Nuzzo,Gian Ludovico Rapaccini,Felice Giuliante.Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ?3<ce:hsp sp="0.25"/>cm. Results of a multicenter Italian survey<!-- Doctopic: CAN -->[J].Journal of Hepatology.2013(1) 被引量:1
  • 8Masaki Kaibori,Shoji Kubo,Hiroaki Nagano,Michihiro Hayashi,Seiji Haji,Takuya Nakai,Morihiko Ishizaki,Kosuke Matsui,Takahiro Uenishi,Shigekazu Takemura,Hiroshi Wada,Shigeru Marubashi,Koji Komeda,Fumitoshi Hirokawa,Yasuyuki Nakata,Kazuhisa Uchiyama,A-Hon Kwon.Clinicopathological Features of Recurrence in Patients After 10-year Disease-free Survival Following Curative Hepatic Resection of Hepatocellular Carcinoma[J].World Journal of Surgery.2013(4) 被引量:1
  • 9Roopinder Gillmore,Sam Stuart,Amy Kirkwood,Ayshea Hameeduddin,Nick Woodward,Andrew K. Burroughs,Tim Meyer.EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization[J].Journal of Hepatology.2011(6) 被引量:3
  • 10Kun Yan,Min Hua Chen,Wei Yang,Yan Bin Wang,Wen Gao,Chun Yi Hao,Bao Cai Xing,Xin Fu Huang.Radiofrequency ablation of hepatocellular carcinoma: Long-term outcome and prognostic factors[J].European Journal of Radiology.2007(2) 被引量:2

共引文献150

同被引文献30

引证文献3

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部